- Another state sues Pfizer over the covid vaccine.
- Only 6 percent of federal workers are working full-time in their offices.
- Academics reject McKinsey study claiming that racial and gender diversity boosted profits.
- More likely to be Trump voters: “county-level data on life expectancy and the prevalence of obesity, diabetes, heavy drinking and regular physical activity (or lack thereof).”
- National Review: When does Robert Hur get his apology?
Category: COVID-19 and Public Health
NYT: The End of Chevron is a Public Health Disaster
The New York Times asked some public health advocates and legal experts what effect the Supreme Court’s repeal of the so-called Chevron Doctrine would have on public health. Apparently, the end of the Chevron Doctrine will hasten the End of the World! “We anticipate that today’s ruling will cause significant disruption to publicly funded health insurance programs, to…
Saturday Links
- What happens when whistleblowers reveal what appears to be medical malpractice associated with “gender affirming care”? The government goes after the whistleblowers.
- More on AI and rural health. (STAT)
- New NBER paper: “Our calculations indicate that currently proposed U.S. policies to reduce pharmaceutical prices, though particularly beneficial for low-income and elderly populations, could dramatically reduce firms’ investment in highly welfare-improving R&D.”
- Could quitting your job actually help the economy?
- Steuerle: “Never in U.S. history has there been so much growth in debt scheduled in current law from past legislation.”
- BMJ publication bias during covid: very one-sided and on the wrong side of history.
- Feds seek delay in releasing covid safety data.
- Do good-looking people live longer?
More on What Motivates Fauci
Both during AIDS and during Covid-19, Fauci and company fought the use of inexpensive, repurposed drugs to help people’s immune systems fight off the threats. [Robert F. Kennedy, Jr.] argues that they were motivated by a desire to bring pharmaceutical products to market—both antivirals and vaccines—without facing cheap competition, as a portion of Big Pharma’s profits would make their way into the public health officials’ pockets.
Quoted in a brief book review by David Henderson, who doesn’t necessarily agree with everything Kennedy has to say on the subject.